EMUDHRA vs EXPLEOSOL: Stock Comparison
EMUDHRA is the larger company by market capitalisation. EMUDHRA shows faster revenue growth and a higher net margin, while EXPLEO SOLUTIONS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
EMUDHRA leads 3; EXPLEOSOL leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| Sector | Information Technology | Information Technology |
| Industry | IT Enabled Services | IT Enabled Services |
Price
| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| Live Price | ₹494.05 | ₹889.5 |
| Day Change | -0.77% | 0.64% |
| Volume | 1.47 L | 9,546 |
| 52-Week High | ₹710.1 | ₹1,175.1 |
| 52-Week Low | ₹364.55 | ₹640 |
| Distance from 52W High | -30.43% | -24.3% |
Valuation
| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| Market Cap | ₹4,097 Cr | ₹1,383 Cr |
| P/E Ratio | 35.62x | 10.02x |
| P/B Ratio | 4.5x | 1.78x |
| EPS | ₹1.5 | ₹18.78 |
| Book Value | ₹110.2 | ₹500.21 |
| Dividend Yield | 0.25% | 12.34% |
Growth
| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| Revenue Growth (TTM YoY) | 31.7% | 11.9% |
| EPS Growth (TTM YoY) | 21.7% | 73.2% |
| Qtr Sales Growth | -65.33% | -12.31% |
| Qtr Profit Growth | -61.19% | -14.75% |
Profitability & Leverage
| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| ROE | 5.59% | 15.97% |
| ROCE | 6.01% | 31.98% |
| Net Margin | 15.75% | 11.19% |
| Operating Margin | 16.77% | 14.87% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | EMUDHRA | EXPLEOSOL |
|---|---|---|
| Promoter Holding | 32.75% | 71.05% |
| FII Holding | 3.92%▲ 0.79 pp | 0.13%▼ 0.29 pp |
| DII Holding | 10.55%▼ 2.79 pp | 0.12%▲ 0.11 pp |
| Public Holding | 31.13%▲ 2.92 pp | 28.7%▲ 0.17 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: EMUDHRA and EXPLEO SOLUTIONS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.